<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">477081703</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180405111451.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170330e19960401xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/BF02722951</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/BF02722951</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Drug-induced reversion of progression phenotype is accompanied by reversion of AP-1 phenotype in JB6 cells</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[V. Lavrovsky, Z. Dong, W. Ma, N. Colburn]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Summary: Transformed JB6 cells can be stably reverted to nontransformed phenotype by AP-1 inhibiting glucocorticoid fluocinolone (FA) and cAMP elevator forskolin (FN), yielding stable revertants of promotion resistant (P−) and promotion sensitive (P+) phenotypes. AP-1 activity of nontransformed P− and P+ revertant clones was decreased under a variety of experimental conditions compared with their transformed counterparts. Moreover, AP-1 activity in P+ cells under anchorage-independent conditions was induced by 12-0-tetradecanoyl-phorbol-13-acetate (TPA) while AP-1 activity in the reverted P− cells was not induced, just as observed for the original P+ and P− variants. Taken together these data suggest that changes in AP-1 activity may be one key mediator not only of forward progression but also of reversion of tumor cells to nontransformed phenotype. In addition, the higher transfection efficiency of the new reverted P− and P+ cells renders them useful for studying the role of transcription factors in tumor promotion.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Society for In Vitro Biology, 1996</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">transformed cells</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">revertant cells</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">AP-1 activity</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Lavrovsky</subfield>
   <subfield code="D">V.</subfield>
   <subfield code="u">Laboratory of Viral Carcinogenesis, NCI-FCRDC, Building 560, Room 21-27, 21702-1201, Frederick, Maryland</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Dong</subfield>
   <subfield code="D">Z.</subfield>
   <subfield code="u">Biological Carcinogenesis and Development Program, PRI/DynCorp., NCI-FCRDC, 21702-1201, Frederick, Maryland</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Ma</subfield>
   <subfield code="D">W.</subfield>
   <subfield code="u">The Hormel Institute, University of Minnesota, 55912, Austin, Minnesota</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Colburn</subfield>
   <subfield code="D">N.</subfield>
   <subfield code="u">Laboratory of Viral Carcinogenesis, NCI-FCRDC, Building 560, Room 21-27, 21702-1201, Frederick, Maryland</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">In Vitro Cellular &amp; Developmental Biology - Animal</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">32/4(1996-04-01), 234-237</subfield>
   <subfield code="x">1071-2690</subfield>
   <subfield code="q">32:4&lt;234</subfield>
   <subfield code="1">1996</subfield>
   <subfield code="2">32</subfield>
   <subfield code="o">11626</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/BF02722951</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/BF02722951</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Lavrovsky</subfield>
   <subfield code="D">V.</subfield>
   <subfield code="u">Laboratory of Viral Carcinogenesis, NCI-FCRDC, Building 560, Room 21-27, 21702-1201, Frederick, Maryland</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Dong</subfield>
   <subfield code="D">Z.</subfield>
   <subfield code="u">Biological Carcinogenesis and Development Program, PRI/DynCorp., NCI-FCRDC, 21702-1201, Frederick, Maryland</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Ma</subfield>
   <subfield code="D">W.</subfield>
   <subfield code="u">The Hormel Institute, University of Minnesota, 55912, Austin, Minnesota</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Colburn</subfield>
   <subfield code="D">N.</subfield>
   <subfield code="u">Laboratory of Viral Carcinogenesis, NCI-FCRDC, Building 560, Room 21-27, 21702-1201, Frederick, Maryland</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">In Vitro Cellular &amp; Developmental Biology - Animal</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">32/4(1996-04-01), 234-237</subfield>
   <subfield code="x">1071-2690</subfield>
   <subfield code="q">32:4&lt;234</subfield>
   <subfield code="1">1996</subfield>
   <subfield code="2">32</subfield>
   <subfield code="o">11626</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
